v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Cash flows from operating activities:    
Net income $ 1,077,243 $ 579,253
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 316,196 309,141
Share-based compensation 57,771 46,238
Gains on investments (33,107) 0
Provision for common stock warrants 14,500  
Provision for doubtful accounts 32,556 21,707
Other 354 3,715
Changes in operating assets and liabilities, net of acquisition of businesses:    
Accounts receivable, net (3,276,790) (266,185)
Receivables from vendors, net 58,330 143,309
Inventories (5,783,606) (654,499)
Accounts payable 4,797,793 135,837
Other operating assets and liabilities 660,564 (247,190)
Net cash (used in) provided by operating activities (2,078,194) 71,326
Cash flows from investing activities:    
Purchases of property and equipment (158,853) (103,989)
Acquisition of businesses, net of cash acquired (7,786) (77,453)
Settlement of net investment hedges (22,699) (347)
Proceeds from sale of investments in equity securities 42,734 0
Other 235 5,032
Net cash used in investing activities (146,369) (176,757)
Cash flows from financing activities:    
Dividends paid (115,648) (110,418)
Proceeds from reissuance of treasury stock 34,267 27,365
Repurchases of common stock (292,368) (423,129)
Repurchases of common stock for tax withholdings on equity awards (7,471) (9,340)
Net borrowings on revolving credit loans 1,638,536 345,099
Principal payments on long-term debt (714,783) (15,541)
Cash paid for debt issuance costs (4,759) 0
Other (9,597) 0
Net cash provided by (used in) financing activities 528,177 (185,964)
Effect of exchange rate changes on cash and cash equivalents 10,299 106,367
Net decrease in cash and cash equivalents (1,686,087) (185,028)
Cash and cash equivalents at beginning of period 2,435,389 1,059,378
Cash and cash equivalents at end of period $ 749,302 $ 874,350